Alector (ALEC) Asset Writedowns and Impairment (2020 - 2025)
Alector (ALEC) reported Asset Writedowns and Impairment of $1.7 million for Q4 2025, up 35080.0% year-over-year from N/an in Q4 2024, and up 35080.0% quarter-over-quarter from -$5000.0 in Q4 2024.
Alector (ALEC) Asset Writedowns and Impairment (2020 - 2025) Analysis & Trends
Alector (ALEC) has 3 years of Asset Writedowns and Impairment data on file, last reported at $1.7 million in Q4 2025.
- Asset Writedowns and Impairment for Q4 2025 came in at $1.7 million, up 35080.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.9 million (up 82.65% YoY), and the FY2025 annual result was $2.9 million, up 31.82% from the prior year.
- Asset Writedowns and Impairment rose to $1.7 million in Q4 2025 per ALEC's latest filing, from -$5000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $2.2 million in Q3 2024 and troughed at -$5000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.75 Mn |
| Dec 31, 2025 | 1.75 Mn |
| Dec 31, 2024 | -5,000.00 |
| Dec 31, 2024 | -5,000.00 |
| Sep 30, 2024 | 2.21 Mn |
| Sep 30, 2024 | 2.21 Mn |
| Dec 31, 2020 | -38,000.00 |
| Dec 31, 2020 | -38,000.00 |